Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections

NCT03846921 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT03846921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03846921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections
Lead sponsor
Hillel Yaffe Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 4, 2019
Completion date
March 31, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, viral infection